Secondary Logo

Journal Logo

Articles by Hadine Joffe, MD

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem

Mitchell, Caroline M.; Srinivasan, Sujatha; Plantinga, Anna; More

Menopause. 25(5):500-507, May 2018.

Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis

Mitchell, Caroline M.; Srinivasan, Sujatha; Zhan, Xiang; More

Menopause. 24(10):1160-1166, October 2017.

Characterizing the trajectories of vasomotor symptoms across the menopausal transition

Tepper, Ping G.; Brooks, Maria M.; Randolph, John F. Jr; More

Menopause. 23(10):1067-1074, October 2016.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial

Caan, Bette; LaCroix, Andrea Z.; Joffe, Hadine; More

Menopause. 22(6):607-615, June 2015.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Efficacy of exercise for menopausal symptoms: a randomized controlled trial

Sternfeld, Barbara; Guthrie, Katherine A.; Ensrud, Kristine E.; More

Menopause. 21(4):330-338, April 2014.

Efficacy of yoga for vasomotor symptoms: a randomized controlled trial

Newton, Katherine M.; Reed, Susan D.; Guthrie, Katherine A.; More

Menopause. 21(4):339-346, April 2014.

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial

Cohen, Lee S.; Joffe, Hadine; Guthrie, Katherine A.; More

Menopause. 21(4):347-354, April 2014.

Methods for the design of vasomotor symptom trials: the Menopausal Strategies Finding Lasting Answers to Symptoms and Health network

Newton, Katherine M.; Carpenter, Janet S.; Guthrie, Katherine A.; More

Menopause. 21(1):45-58, January 2014.

Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol

Joffe, Hadine; White, David P.; Crawford, Sybil L.; More

Menopause: The Journal of The North American Menopause Society. 20(9):905-914, September 2013.

Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the Menopause Strategies Finding Lasting Answers for Symptoms and Health Research Network

Joffe, Hadine; Guthrie, Katherine A.; Larson, Joseph; More

Menopause: The Journal of The North American Menopause Society. 20(3):261-268, March 2013.

Association of past and recent major depression and menstrual characteristics in midlife: Study of Women’s Health Across the Nation

Bromberger, Joyce T.; Schott, Laura L.; Matthews, Karen A.; More

Menopause: The Journal of The North American Menopause Society. 19(9):959-966, September 2012.

Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial

Ensrud, Kristine E.; Joffe, Hadine; Guthrie, Katherine A.; More

Menopause: The Journal of The North American Menopause Society. 19(8):848-855, August 2012.

Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy

Rogines-Velo, Maria Pia; Heberle, Amy E.; Joffe, Hadine

Menopause. 19(4):471-475, April 2012.

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial

Joffe, Hadine; Partridge, Ann; Giobbie-Hurder, Anita; More

Menopause. 17(5):908-916, September-October 2010.

Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms

Joffe, Hadine; Soares, Claudio N.; Thurston, Rebecca C.; More

Menopause. 16(4):671-679, July-August 2009.

Beyond frequency: who is most bothered by vasomotor symptoms?

Thurston, Rebecca C.; Bromberger, Joyce T.; Joffe, Hadine; More

Menopause. 15(5):841-847, September 2008.

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life

Soares, Claudio N.; Arsenio, Helga; Joffe, Hadine; More

Menopause. 13(5):780-786, September-October 2006.

Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles

Thurston, Rebecca C.; Joffe, Hadine; Soares, Claudio N.; More

Menopause. 13(4):553-560, July-August 2006.

Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women

Joffe, Hadine; Hall, Janet E.; Gruber, Staci; More

Menopause. 13(3):411-422, May-June 2006.